EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in Gliomas

Capucine Cadin, Stefano Casagranda iD, François Xavier Lejeune iD, Marianne Golse, Bertrand Mathon iD, Ottavia Dipasquale, Christos Papageorgakis, Mauro Zucchelli, Emmanuel Mandonnet, Stéphane Lehéricy, Franck Bielle iD, Marc Sanson und 4 weitere

NMR in Biomedicine · 2026

DOI: 10.1002/nbm.70372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, 2026. Verfasst von Capucine Cadin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Paris Brain Institute - ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, UMR S 1127, Equipe labellisée LNCC, Paris, France. Hauptthemen laut MEDLINE: Glioma, Isocitrate Dehydrogenase, Mutation, Magnetic Resonance Imaging. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion are key molecular markers for glioma classification. Amide proton transfer weighted (APTw) and nuclear Overhauser effect–weighted (NOEw) markers showed promise for glioma characterization, by probing protein‐related tissue properties. However, their interpretation is confounded by direct water saturation, macromolecules (semi‐solid magnetization transfer—ssMT), and T 1 relaxation. Here, we aimed to assess the performance of three APTw and NOEw metrics—uncorrected, spillover/ssMT‐corrected (FMC), and fully spillover/ssMT‐ and T 1 ‐corrected (FMTC)—for glioma stratification. Fifty patients with suspected gliomas were prospectively enrolled (12 IDH‐wild‐type, 38 IDH‐mutant, of which 21 with 1p/19q codeletion). Acquisitions were performed at 3 T using a 3D gradient echo readout with chemical exchange saturation transfer ( B 1 = 2 μT for APTw, 0.6 μT for NOEw; T 1sat = 2 s), WASABI (WAter Shift And B1) for B 0 / B 1 mapping, and saturation recovery for T 1 mapping. Glioma subtypes were compared using metrics extracted from manually segmented masks, using two‐tailed Mann–Whitney U tests, and the Benjamini–Hochberg false discovery rate (FDR) correction. Effect sizes were quantified using Cliff's δ with 95% bootstrap confidence intervals and classification performance was assessed by receiver operating characteristic analyses (area under the curve, AUC). IDH‐mutant and wild‐type gliomas differed significantly for the uncorrected APTw metric ( p = 0.005, AUC = 0.79), with stronger discrimination following correction—APTw‐FMC ( p < 0.001, AUC = 0.94) and APTw‐FMTC ( p < 0.001, AUC = 0.96), both with large effect sizes. Only APTw‐FMTC distinguished 1p/19q codeleted from non‐codeleted gliomas before FDR correction (uncorrected p = 0.01, AUC = 0.74). The NOEw metrics did not differ between any molecular subgroups, likely due to limited sensitivity of this contrast at 3 T. These results suggest that correcting for fluid, ssMT, and T 1 effects enhances the accuracy of APTw metrics, offering a more robust and biophysically grounded approach to noninvasive glioma diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaIsocitrate DehydrogenaseMutationMagnetic Resonance ImagingChromosomes, Human, Pair 1Brain NeoplasmsChromosomes, Human, Pair 19HumansFemaleMaleMiddle AgedAdultROC CurveAged

Stichwörter der Autor:innen

1p/19q codeletionAPTw‐CESTIDHNOEwglioma diagnosisprotein‐related markers

Substanzen

Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Paris Brain Institute - ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, UMR S 1127, Equipe labellisée LNCC, Paris, France.
  • Department of R&D Advanced Applications, Olea Medical, La Ciotat, France.
  • Data Analysis Core, Paris Brain Institute, Paris, France.
  • Department of Neuroradiology, La Pitié Salpêtrière Hospital, AP-HP, Paris, France.
  • Department of Neurosurgery, La Pitié Salpêtrière Hospital, AP-HP Sorbonne University, Paris, France.
  • Department of Neurosurgery, Lariboisière Hospital, AP-HP, Paris, France.

ORCID-Profile: Stefano Casagranda, François Xavier Lejeune, Bertrand Mathon, Franck Bielle, Moritz Zaiss, Lucia Nichelli, Francesca Branzoli

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Cadin, C., Casagranda, S., Lejeune, F. X., Golse, M., Mathon, B., Dipasquale, O., Papageorgakis, C., Zucchelli, M., Mandonnet, E., Lehéricy, S., Bielle, F., Sanson, M., Liebig, P., Zaiss, M., Nichelli, L., & Branzoli, F. (2026). Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in Gliomas. NMR in Biomedicine. https://doi.org/10.1002/nbm.70372

Vancouver

Cadin C, Casagranda S, Lejeune FX, Golse M, Mathon B, Dipasquale O, et al. Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in Gliomas. NMR in Biomedicine. 2026. doi:10.1002/nbm.70372

BibTeX
@article{Cadin2026,
  author = {Cadin, Capucine and Casagranda, Stefano and Lejeune, François Xavier and Golse, Marianne and Mathon, Bertrand and Dipasquale, Ottavia and Papageorgakis, Christos and Zucchelli, Mauro and Mandonnet, Emmanuel and Lehéricy, Stéphane and Bielle, Franck and Sanson, Marc and Liebig, Patrick and Zaiss, Moritz and Nichelli, Lucia and Branzoli, Francesca},
  title = {Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in Gliomas},
  journal = {NMR in Biomedicine},
  year = {2026},
  doi = {10.1002/nbm.70372}
}
Kostenlos starten →